checkAd

    AKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana  298  0 Kommentare Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKER

    Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Akers Biosciences, Inc. (NasdaqCM: AKER) with MyMD Pharmaceuticals, Inc., pursuant to which Akers shareholders will end up owning just 20% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

    If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-aker/ to learn more.

    To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

    Lesen Sie auch





    Business Wire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von Business Wire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    AKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKER Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Akers Biosciences, Inc. (NasdaqCM: AKER) with MyMD Pharmaceuticals, Inc., pursuant to which …